Drug Profile
Oxycodone controlled-release - GL PharmTech
Alternative Names: GL2907; GL2907 XL; Oxycodone QD; Oxycodone XLLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator GL PharmTech
- Class Alkaloids; Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pain in South Korea (PO, Controlled release)
- 13 Mar 2014 GL PharmTech announces intention to submit NDA by early 2015
- 01 Aug 2013 GL PharmTech completes a phase I trial in Healthy volunteers in South Korea (NCT01779492)